The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it none, with a mean price target of $47.
Sturm, Ruger & Co Inc
RGR · the NYSE · USD · Market cap $629M · 1,780 employees
Sturm, Ruger & Company, Inc., together with its subsidiaries, designs, manufactures, and sells firearms under the Ruger name and trademark in the United States.
FAIL · Does not pass the screenAt the last full screen
2026-06-14
Screened 2026-06-14 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Sturm, Ruger & Co Inc holds its Accumulation at $39.47. Consolidating, no directional conviction, held for 49 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 49 days |
| Price at the screen | $39.47 |
| Valuation | N/A trailing · 19.93 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.22 |
Five Screens, Shown in Full
Does not pass. Excluded industry: Aerospace & Defense
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Excluded industry: Aerospace & Defense | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Conscience OverlayThe quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate / Don’t Buy Into Occupation / Who Profits Corporate Database — category: Corporate Complicity Report / Annex 2 Company List. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Fair value range in USD, drawn from the 2026-06-14 screen. The gold marker is the market price at the same screen. The price runs 13.2% above the base estimate.
Third-party analyst targets: 2 covering, consensus None. The average target sits +19% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-06-14 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 19.9xexpensive even after accounting for its growth |
| EPS, trailing | -0.73 |
| EPS, forward | 1.98 |
| Revenue growth | +4.1%slow but positive growth |
| Profit margin | -2.2%currently unprofitable |
| Return on equity | -4.0%not currently earning a positive return on equity |
| Dividend yield | 111.00% |
| Debt to equity | 0.58moderate, manageable leverage |
| Beta | 0.22barely tracks the market's swings |
| 52-week range | 28.33 - 48.21 |
| Moat | NONE |
| Market cap | $629M |
| Employees | 1,780 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeRGR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it none, with a mean price target of $47.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (2 analysts) rates it none, with a mean price target of $47.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $37.47 | +3.8% | $0.11 | $1,041 | +4.1% |
| 2 months | $40.85 | -4.8% | $0.11 | $955 | -4.5% |
| 3 months | $38.51 | +1.0% | $0.19 | $1,015 | +1.5% |
| 6 months | $33.29 | +16.8% | $0.19 | $1,174 | +17.4% |
| 1 year | $37.32 | +4.2% | $0.39 | $1,053 | +5.3% |
| 2 years | $41.63 | -6.6% | $1.11 | $961 | -3.9% |
| 3 years | $49.64 | -21.7% | $2.03 | $824 | -17.6% |
| 5 years | $64.04 | -39.3% | $11.98 | $794 | -20.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever RGR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.